Updated:
Frontline BioVentures
Frontline BioVentures is a venture capital based in Hong Kong, founded 2012; the Altss profile covers its classification, headquarters, registration, AUM band,...
Frontline BioVentures
Frontline BioVentures is an SEC-registered investment adviser in HONG KONG, established in 2018. It has been registered with the SEC since then.
General information
Firm type
Venture Capital
Year founded
2012
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Hong Kong
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What investment stages does Frontline BioVentures target?
The firm covers seed, startup, growth, and buyout stages within life sciences and biotechnology. This range allows it to participate from early research through to commercial-stage companies. The dual venture-and-buyout approach is relatively rare among healthcare-focused investors in China.
Which sectors does Frontline BioVentures focus on?
Frontline BioVentures invests exclusively in healthcare, specifically biotechnology, life sciences, and related sub-sectors such as therapeutics, diagnostics, and medical devices. No public information indicates investments outside of this domain.
Is Frontline BioVentures structured as a family office or an institutional asset manager?
The firm is classified as a private equity asset manager, not a family office. Its strategy includes both venture capital and buyout deals, typical of institutional investment firms. No disclosed ties to a specific family or endowment have been found.
Does Frontline BioVentures participate in fund commitments or only direct deals?
The firm primarily makes direct investments in portfolio companies. It may also engage in syndicates or co-investments alongside other healthcare-focused funds. No evidence of fund-of-funds or third-party fund commitments exists in public records.
Where is Frontline BioVentures headquartered?
The firm is based in Shanghai, China. No additional office locations have been identified in public sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: